LongLFCRSep 2026
Lifecore Biomedical, Inc.
Greenhaven's thesis centers on monetizing Lifecore's excess pharmaceutical manufacturing capacity. The company added seven customers in nine months, including at least two that…
LFCR
Which hedge funds are long LFCR?
1 published idea on Lifecore Biomedical, Inc. across 1 fund — 1 long and 0 short.
Lifecore Biomedical hedge fund investment theses
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Lifecore Biomedical: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.